WHO Collaborating Centre for
Pharmaceutical Pricing and Reimbursement Policies

SelectedTerm ABC analysis Access Access with evidence development (AED) Accreditation Active ingredient Actor Acute care Acute care beds Adherence Advanced therapy medicinal product Adverse reaction Affordability Allocative efficiency Analogous substitution Anatomical, therapeutic, chemical classification Authority Average length of stay Batch Benchmark Bioavailability Bioequivalence Biological marker Biological medicinal product Blood establishment Branch pharmacy Brand name Budget impact Budget impact analysis Bulk product Bundling Burden of disease Cancer Capitation Carriage and insurance packaging Case-mix Catchment area Centralised procedure Chronic care Chronic condition Claw-back Clinical endpoint Clinical paths Clinical pharmacology Clinical trial Combination product Community care Community pharmacy Co-morbid condition Competitive negotiations Complication Compulsory health insurance Conditional Coverage Conditional marketing authorisation Conditional treatment continuation (CTC) Consignment Consumption Consumption-based reimbursement Container Co-payment Cost-benefit analysis Cost-containment Cost-effectiveness Cost-effectiveness analysis Cost-free medicines Cost, insurance and freight Cost-plus pricing Cost-sharing Counterfeit medical product Coverage Coverage with evidence development (CED) Curative care beds Day care Decentralised procedure Deductible Defined daily dose De-listing Delivery chain Diagnosis related groups Direct payments Direct procurement Disability-adjusted life years Disability-free life expectancy Discount Disease Disease-specific reimbursement Dispensing Dispensing doctors Dispensing fee Distance selling Distribution Distribution actors Effectiveness Efficacy Efficiency Eligibility scheme(s) Emergency Emergency unit End users of pharmaceutical Essential medicines Excipient Ex-factory price Extemporaneous preparation External price referencing Fee-for service Fixed co-payment Fixed dose combination Product Free pricing Gatekeeper General hospital General practitioner Generic Generic policies Generic substitution Gene therapy medicinal product Global budgeting Good clinical practice Good distribution practices Good manufacturing practices Gross domestic product Group purchasing Guideline Haemovigilance Health Health care provider Health economics Health establishment Health expenditure Health information Health status Health technology Health technology assessment Herbal medicinal product Herbal preparations Herbal substances High-cost patient High-risk patient High-risk procedures High-risk products Home care Homeopathic medicinal product Hospice Hospital Hospital admission Hospital association Hospital beds Hospital blood bank Hospital day Hospital discharge Hospital-only medicines Hospital pharmaceutical formulary Hospital pharmacy Hospital price Hospital purchasing body Hospitalisation rate Hospital pharmacist Hospital pharmacy specialist Human medicine Illness Indicators Informal payments Infusion Injectable medicines In-patient care Interchangeable pharmaceutical product Interface management Internal price referencing International classification of diseases International classification of functioning, disability and health International classification of health problems in primary care International classification of primary care International non-proprietary name International non-proprietary name prescribing Internet pharmacy Length of stay Life expectancy Line-item budgeting List price Long term care Long term care beds in hospitals Long term care beds in nursing and residential care facilities Magistral formula Major diagnostic category Managed entry agreements Manufacturer Margin Marginal cost Mark-up Marketing authorisation Marketing authorisation under exceptional circumstances Market player Maximum price Medical device Medical record Medical services Medication compliance Medication error Medication persistence Medication reconciliation Medicine Mental health and substance abuse hospital Me-too medicine Mortality rate Multi-channel system Mutual recognition procedure National health service National procedure Negative list New molecular entity Nurse Occupancy rate Officinal formula Off-label prescribing Off-patent medicine Only in research (OIR) Only with research On-patent medicine Open tender Order Order entry Original product Orphan medicine Outcome Outcomes guarantees Outcome indicators Outlier Out-of pocket maximum Out-of pocket payments Out-patient care Out-patient clinics Out-patient facilities Out-patient department Out-patient physician Overhead Over prescribing Over-the-counter medicine Palliative care Parallel trade Paramedicines Patient access scheme (PAS) Pattern or process care Pay-back Percentage co-payment Performance based agreement Performance based health outcome reimbursement schemes Performance-linked reimbursement Pharmaceutical alternatives Pharmaceutical and therapeutic committee Pharmaceutical budget Pharmaceutical care Pharmaceutical depot Pharmaceutical equivalence Pharmaceutical expenditure Pharmaceutical form Pharmaceutical promotion Pharmaceutical provision Pharmaceutical sample Pharmaceutical service Pharmaceutical system Pharmacist Pharmacoecomic evaluation Pharmacological class Pharmacopoeia Pharmacovigilance Pharmacy chain Pharmacy outlet Pharmacy purchasing price Pharmacy retail price Pharmacy tax Physician Policy maker Polypharmacy Population-group-specific reimbursement Positive list Prescription Prescription fee Prescription guidelines Prescription monitoring Prescription- only medicines Prescription-only medicines dispensary Prevalence Price cap Price control Price cut Price freeze Price negotiation Price notification Price type Price-volume agreement Pricing Pricing committee Pricing policies Pricing procedure Primary care Private health expenditure Private pharmaceutical expenses Process indicators Procurement Procurement agency Procurement methods Product-specific reimbursement Profit control Psychiatric care beds Public health expenditure Purchaser’s price Purchasing committee Purchasing for safety Purchasing power parities Quality assurance Quality control Quality system Quality-adjusted life years Radiation therapy Rate Rational use of medicines Rebate Recall Reference price system Referral Registration Reimbursement Reimbursement category Reimbursement list Reimbursement market Reimbursement price Reimbursement rate Reimbursement scheme Relative effectiveness Relative efficacy Remuneration Restricted tender Retailer Risk Risk-benefit balance Risk-sharing schemes Secondary care Self-medication Sentinel event Sickness fund Single-channel system Social health insurance Somatic cell therapy medicinal product Speciality hospital Stakeholder Standard of care Statutory pricing Sterile product Stock-taking Storage Structural indicators Supplementary protection certificate Supplier Surgery day care Surgical procedures Surrogate endpoint Sustainability Switch System of Health Accounts Taxation Taxonomy Technical efficiency Tender Therapeutic benefit Therapeutic equivalence Therapeutic group Therapeutic referencing Tertiary care Third party payer Tissue engineered product Tissue establishment Traceability of pharmaceuticals Transaction Transparency directive Value added tax Volume control Voluntary health insurance Vulnerable groups Wholesale Wholesale outlet